Diageo: June Spirits Rebound Is A Flicker, Not A Recovery

Generated by AI agentIsaac LaneReviewed byTianhao Xu
3min read
en_chrisen_archer
AI Podcast:Your News, Now Playing

- DiageoDEO-- faces declining U.S. spirits sales (-15.4% Q3 2026) and $8.6B aged inventory pile, with North America as its "biggest challenge."

- June's 4.8% volume rebound is isolated against 12-month declines (-0.5%), with recovery unlikely without sustained Q4 growth.

- Valuation remains premium (20.4x P/E vs. peers) despite -2.0% YoY revenue growth and 94% payout ratio after dividend cut.

- August 6 earnings report will determine if mass-market/RTD pivots offset premium category declines and stabilize North America.

Diageo trades at a premium multiple on a business that is shrinking in its largest market, bleeding cash flow, and sitting on a record pile of unsold spirits. June volume data offers a flicker of improvement, but the company's next earnings report on August 6 will determine whether that flicker is the start of a trend or just seasonal noise. The stock has fallen roughly 20% over the past year, but at current levels it still costs more than slower-growth peers. Hold.

What the market is reading into June

U.S. control-state spirits volumes rose 4.8% in June 2026, with American whiskey (+2.9%), vodka (+1.1%), and tequila (+6.4%) back in growth territory after months of sequential declines. On-premise volumes jumped 6.2%. Canned ready-to-drink cocktails surged 33.7%.

That sounds like recovery. It isn't. Twelve-month trailing control-state spirits volumes are still down 0.5%, and value sales are down 2.5%. Only the "cocktails" segment and cachaça showed growth in May, the prior month. A single rebound month against a 12-month decline is not a trend. It is a data point that removes the tail from the selloff narrative.

Bernstein's Trevor Stirling, who first sounded the alarm on record inventory buildups in January, has been among those noting June's uptick while maintaining that the broader spirits cycle has not turned. Stirling flagged $22.37 billion in accumulated aged spirits inventory across the five largest listed producers in January - more than after the 2008 financial crisis. DiageoDEO-- alone carries roughly $8.6 billion in aged inventory, up from 34% of annual revenue in fiscal 2022 to 43% in fiscal 2025. That pile takes years to clear because spirits age in barrels before they can be sold.

Diageo's operating picture is still deteriorating

Diageo's third quarter - the three months ending March 31, 2026 - showed organic sales up just 0.3% globally. North America, which accounts for 38% of revenue, fell 9.4% organically. U.S. spirits sales dropped 15.4%. Tequila, a high-margin premium category that once drove growth, suffered double-digit declines.

CEO Dave Lewis, who took over on January 1, called North America the company's "biggest challenge" and said its offer "needs to be more competitive." He has pivoted toward the mass market, where Diageo is underrepresented, and is betting on ready-to-drink cocktails, where the company's share has fallen from over 25% in the Smirnoff Ice era to below 10% today.

That pivot is the right one. It takes time, and it takes volume. The first full earnings report under Lewis, covering fiscal 2026, lands on August 6. Consensus expects full-year revenue of roughly $20 billion (down 1.1%) and EPS of $6.34 (down 3.5%). Diageo's own guidance calls for organic sales to decline 2–3%.

Revenue growth year-over-year across the trailing twelve months is negative 2.0%. Free cash flow growth is down 7.9%. The business is not just flat - it is contracting on both the top and bottom lines.

Valuation still implies a premium business

This is where the stock becomes harder to justify.


MetricDiageo (DEO)Brown-Forman (BF.B)Constellation Brands (STZ)
P/E (TTM)20.4x17.8x12.3x
EV/EBITDA12.5x13.7x10.1x
Dividend Yield3.7%3.3%3.2%
Revenue Growth YoY–2.0%--

Diageo trades at a 15% P/E premium to Brown-Forman and a 66% premium to Constellation Brands. On an EV/EBITDA basis, it is the cheapest of the three, but that reflects its heavy debt load ($36.6 billion in total debt, $21.3 billion net debt, 172% debt-to-equity), not operational efficiency. Constellation Brands, which pivoted away from beer into higher-margin wine and spirits decades ago, generates operating leverage at a fraction of the multiple.

The 3.7% dividend yield looks attractive until you check the payout ratio: 94%. Diageo just cut its dividend in half, to 20 cents per share, to preserve cash. A payout ratio near 100% means the company is spending almost every dollar of earnings on dividends, leaving little room for reinvestment or margin error. If earnings decline further - and the guidance suggests they might - that yield is at risk of another cut.

The cheap-enough bridge doesn't quite get there

Diageo's stock has fallen from a 52-week high of $116.41 to roughly $88.51. That is a meaningful reset. At 20.4x trailing earnings and 12.5x EV/EBITDA, the stock is not trading like a growth compounder anymore. But neither is the business shrinking enough to call this deeply discounted.

The scenario where this stock becomes a buy is straightforward: the August 6 full-year report shows North America stabilizing, June's rebound holds through Q4, and management outlines a credible path for the mass-market and RTD pivots to offset premium tequila and Scotch declines. If that happens, the 94% payout ratio could be rationalized as a temporary measure, and the stock could recover toward $100–$110.

The scenario where it keeps falling is also clear: U.S. volumes remain flat or decline, inventory overhang forces discounting on aged Scotch and tequila, the mass-market pivot drags gross margins (currently 59.7%), and another dividend cut becomes inevitable. At that point, a stock trading at 20x earnings on negative growth starts to look expensive by any measure.

What to watch

The catalyst clock is set. August 6 is the date. The questions to answer then:

  • Did Q4 North America trends improve sequentially from Q3's 9.4% organic decline?
  • Is the RTD mass-market pivot showing any revenue traction, or is it still just strategy talk?
  • Does management reaffirm the 2–3% organic sales decline, or is the guidance reset again?
  • Will the dividend hold, or is the 94% payout ratio a one-quarter fluke before another cut?

Until those answers arrive, June's 4.8% volume rebound is a data point, not a thesis. The valuation has reset, but not enough to justify buying a business that is still losing ground in its largest market, carrying heavy debt, and paying out nearly all its earnings as dividends. Hold for the August report.